Utilizing Fibrosis-4 score to assess risk for hepatic fibrosis in patients with psoriasis on methotrexate

Int J Dermatol. 2021 Mar;60(3):e100-e101. doi: 10.1111/ijd.15201. Epub 2020 Sep 29.

Authors

Elizabeth Yim^{1

2}, Alana Deutsch², Roya S Nazarian^{2

3}, Beth N McLellan², Danielle Espinoza², Allan W Wolkoff⁴, Steven R Cohen²

Affiliations

¹ Division of Dermatology, University of California, Los Angeles, CA, USA.
² Division of Dermatology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.
³ Icahn School of Medicine at Mount Sinai, New York, NY, USA.
⁴ Division of Hepatology, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, USA.

PMID: 32989752
DOI: 10.1111/ijd.15201

No abstract available

Publication types

Letter

MeSH terms

Humans
Liver / pathology
Liver Cirrhosis / pathology
Methotrexate* / adverse effects
Psoriasis* / drug therapy
Psoriasis* / pathology

Substances

Methotrexate